GenScript: Leading Supplier for Cell Therapy Solutions with Miltenyi

We are excited to announce a new collaboration between Genscript and T&L Biotechnology Co., Ltd. that has resulted in the development of a cutting-edge biotechnology product. This innovative product combines Genscript's expertise in genetic engineering and T&L Biotechnology Co., Ltd.'s proficiency in bioprocessing to offer a unique solution for the biotechnology industry, Our joint efforts have led to the creation of a novel protein expression platform that promises to revolutionize the production of recombinant proteins. This platform utilizes Genscript's world-class gene synthesis technology and T&L Biotechnology Co., Ltd.'s state-of-the-art bioreactor systems to enable efficient and high-yield production of a wide range of proteins, The partnership between Genscript and T&L Biotechnology Co., Ltd. aims to provide researchers and industry professionals with a reliable and cost-effective solution for their protein expression needs. With our combined expertise and resources, we are confident that this new product will contribute to advancements in biotechnology and accelerate research and development in various fields, We look forward to bringing this groundbreaking product to the market and making a significant impact on the biotechnology industry